145 related articles for article (PubMed ID: 22773013)
1. Genetic variants in TP53 and MDM2 associated with male infertility in Chinese population.
Huang C; Liu W; Ji GX; Gu AH; Qu JH; Song L; Wang XR
Asian J Androl; 2012 Sep; 14(5):691-4. PubMed ID: 22773013
[TBL] [Abstract][Full Text] [Related]
2. The frequency of
Ebrahim Abadi Z; Khademi Bami M; Golzadeh M; Kalantar SM; Sheikhha MH
Int J Reprod Biomed; 2018 Aug; 16(8):491-496. PubMed ID: 30288482
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of MDM2 and TP53 genes are associated with risk of nasopharyngeal carcinoma in a Chinese population.
Xiao M; Zhang L; Zhu X; Huang J; Jiang H; Hu S; Liu Y
BMC Cancer; 2010 Apr; 10():147. PubMed ID: 20398418
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
[TBL] [Abstract][Full Text] [Related]
5. A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population.
Alshatwi AA; Hasan TN; Shafi G; Alsaif MA; Al-Hazzani AA; Alsaif AA
Fundam Clin Pharmacol; 2012 Jun; 26(3):438-43. PubMed ID: 21477265
[TBL] [Abstract][Full Text] [Related]
6. Association of TP53 rs1042522 G > C, MDM2 rs2279744 T > G, and miR-34b/c rs4938723 T > C polymorphisms with aneuploidy pregnancy susceptibility.
Chan Y; Xu W; Feng Y; Zhang Y; Li S; Geng Z; Liu Z; Zhao Q; Zhang J; Zhu B
BMC Pregnancy Childbirth; 2023 Aug; 23(1):624. PubMed ID: 37648962
[TBL] [Abstract][Full Text] [Related]
7. Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.
Schmidt MK; Tommiska J; Broeks A; van Leeuwen FE; Van't Veer LJ; Pharoah PD; Easton DF; Shah M; Humphreys M; Dörk T; Reincke SA; Fagerholm R; Blomqvist C; Nevanlinna H
Breast Cancer Res; 2009; 11(6):R89. PubMed ID: 20021639
[TBL] [Abstract][Full Text] [Related]
8. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
[TBL] [Abstract][Full Text] [Related]
9. No association of TP53 codon 72 SNP with male infertility: a study in a Chinese population and a meta-analysis.
Chan Y; Jiang H; Ma L; Chen J; Li D; Meng Y; Luo Y; Tang W
Syst Biol Reprod Med; 2015; 61(4):222-7. PubMed ID: 25747431
[TBL] [Abstract][Full Text] [Related]
10. The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.
Hong Y; Miao X; Zhang X; Ding F; Luo A; Guo Y; Tan W; Liu Z; Lin D
Cancer Res; 2005 Oct; 65(20):9582-7. PubMed ID: 16230424
[TBL] [Abstract][Full Text] [Related]
11. Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer.
Yang M; Guo Y; Zhang X; Miao X; Tan W; Sun T; Zhao D; Yu D; Liu J; Lin D
Carcinogenesis; 2007 Sep; 28(9):1996-2001. PubMed ID: 17638920
[TBL] [Abstract][Full Text] [Related]
12. p53 signaling pathway polymorphisms associated to recurrent pregnancy loss.
Fraga LR; Dutra CG; Boquett JA; Vianna FS; Gonçalves RO; Paskulin DD; Costa OL; Ashton-Prolla P; Sanseverino MT; Schuler-Faccini L
Mol Biol Rep; 2014 Mar; 41(3):1871-7. PubMed ID: 24435975
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
Gynecol Oncol; 2009 Apr; 113(1):109-14. PubMed ID: 19193430
[TBL] [Abstract][Full Text] [Related]
14. Genetic variations in MDM2 and P53 genes confer risk for adult acute lymphoblastic leukemia in a Chinese population.
Chen J; Zhu B; Chen J; Li Y
DNA Cell Biol; 2013 Jul; 32(7):414-9. PubMed ID: 23745682
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of p53 and MDM2 genes are associated with severe toxicities in patients with non-small cell lung cancer.
Zheng D; Chen Y; Gao C; Wei Y; Cao G; Lu N; Hou Y; Jiang X; Wang J
Cancer Biol Ther; 2014; 15(11):1542-51. PubMed ID: 25482940
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis.
Gansmo LB; Lie BA; Mæhlen MT; Vatten L; Romundstad P; Hveem K; Lønning PE; Knappskog S
Gene; 2021 Aug; 793():145747. PubMed ID: 34077778
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies.
Elshazli RM; Toraih EA; Elgaml A; Kandil E; Fawzy MS
Gene; 2020 Apr; 734():144391. PubMed ID: 32001373
[TBL] [Abstract][Full Text] [Related]
18. Association between TP53 gene Arg72Pro polymorphism and idiopathic infertility in southeast Chinese Han males.
Jin Q; Wang B; Wang J; Liu T; Yu X; Jia C; Fang X; Peng Y; Ma X
Syst Biol Reprod Med; 2013 Dec; 59(6):342-6. PubMed ID: 24266512
[TBL] [Abstract][Full Text] [Related]
19. Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer.
Han JY; Lee GK; Jang DH; Lee SY; Lee JS
Cancer; 2008 Aug; 113(4):799-807. PubMed ID: 18618574
[TBL] [Abstract][Full Text] [Related]
20. Association of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC).
Yang J; Liu B; Li W; Xiong H; Qiu H; Fu Q; Chen B; Hu G; Yuan X
Cancer Epidemiol; 2013 Oct; 37(5):629-33. PubMed ID: 23837945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
